Radioembolization

Radioembolization represents a significant advancement in the fight against liver cancer, offering a modern and minimally invasive approach to treating complex tumors. This sophisticated radioembolization treatment delivers high doses of radiation directly to cancerous cells within the liver while meticulously preserving the surrounding healthy tissue. The procedure involves introducing tiny radioactive microspheres into the tumor’s blood supply, which provides a concentrated therapeutic effect precisely where it is needed. This innovative radioembolization treatment offers a crucial option for patients, particularly those for whom conventional surgery is not suitable, by effectively controlling tumor growth and improving outcomes through a highly focused strategy.

What is Radioembolization?

Radioembolization is an advanced treatment designed to target liver tumors. This minimally invasive procedure delivers what can be described as tiny “smart radiation beads” directly into the blood vessels that supply the tumor. These beads then lodge in the tumor’s blood vessels, where they emit a high dose of radiation directly to cancer cells while largely sparing the surrounding healthy liver. The treatment is considered minimally invasive because it is performed with a catheter through a small incision, typically in the groin, avoiding the need for major surgery and offering patients a less traumatic experience.

What are the key features of Radioembolization?

Radioembolization is distinguished by several core characteristics that make it a highly effective and advanced treatment for liver tumors:

• Targeted Radiation: The treatment delivers high-dose radiation directly to the tumor, precisely targeting cancerous cells while minimizing damage to the surrounding healthy liver tissue.
• Minimally Invasive: It is performed through a small incision, typically in the groin or wrist, using a catheter. This approach avoids major surgery, leading to a faster recovery for the patient.
• Microsphere-Based: The therapy uses microscopic radioactive spheres that are infused into the tumor’s blood supply, where they become lodged and deliver localized, sustained radiation.

In which diseases can it be used?

Radioembolization is a critical therapeutic option for various forms of liver cancer. Its primary application is in treating primary liver cancer (hepatocellular carcinoma – HCC), especially when surgical removal is not possible due to the tumor’s size, location, or the patient’s overall health. Furthermore, it is an effective treatment for cancers that have spread (metastasized) to the liver from other organs, such as colorectal, breast, and neuroendocrine tumors. For patients where systemic therapies are unsuitable or have failed, this targeted approach can control disease progression, reduce tumor size, and improve quality of life.

Which method is used for Radioembolization?

Radioembolization is performed using two main types of microspheres. The first, TheraSphere, consists of glass-based microspheres, while the second, SIR-Spheres, is made from resin beads. Both methods utilize a radioactive isotope called yttrium-90 to target and destroy tumor cells. These microscopic beads are delivered directly into the tumor’s blood supply, where the embedded yttrium-90 emits localized radiation. This targeted approach effectively treats the cancer while minimizing exposure to the surrounding healthy liver tissue.

How is it applied?

Radioembolization is a precise, multi-stage process carefully designed for patient safety and treatment effectiveness. The procedure follows specific steps:

1.  Planning and Mapping: A few days before the treatment, an initial angiography is performed. This procedure maps the blood vessels that supply the tumor, allowing doctors to plan the delivery route and protect the surrounding healthy liver tissue and other organs. This step is crucial for ensuring the radioactive particles are delivered only to the intended target.

2.  The Procedure and Delivery: During the treatment, a thin, flexible tube called a catheter is inserted into the body through a small incision, typically in the groin or wrist. Guided by real-time X-ray imaging, this catheter is carefully navigated to the artery in the liver that feeds the tumor. Once it is in the correct position, radioactive microspheres are slowly delivered through the catheter directly into the tumor’s blood supply.

This highly specialized procedure is performed by interventional radiologists, doctors with advanced training in minimally invasive, image-guided therapies. Their expertise ensures the radioactive beads are placed with precision, maximizing the treatment’s impact on the tumor while minimizing side effects.

How long does the application/procedure take?

The radioembolization treatment itself, involving the delivery of radioactive microspheres, typically takes one to two hours. However, the complete process is scheduled across two separate appointments. The initial session is dedicated to mapping the blood vessels of the liver. The actual treatment procedure is then performed in a second session, which usually takes place a few weeks later. This separation allows for precise planning to ensure the safety and effectiveness of the therapy.

Is the Radioembolization procedure painful?

The radioembolization procedure is designed to be as comfortable as possible and is generally not considered painful. Before the treatment begins, the area where the catheter will be inserted, typically in the groin or wrist, is completely numbed with a local anesthetic. Consequently, instead of sharp pain, a slight sensation of pressure may be felt at the insertion site. Most patients are comfortable throughout the procedure, and a mild sedative can also be administered to help the patient relax and minimize any potential discomfort.

Which patients is it applied to?

Radioembolization is typically applied to patients with liver cancer tumors that cannot be surgically removed. The best candidates for this treatment are individuals whose disease is predominantly confined to the liver. Additionally, the therapy can serve as a “bridge” to surgery; by shrinking the tumor, it may allow a patient who was previously ineligible for an operation to become a surgical candidate, potentially improving their long-term outcome.

Who is not suitable for Radioembolization application?

Radioembolization is not a suitable treatment for every patient. A detailed evaluation is necessary to ensure safety and effectiveness. The procedure is generally not recommended for individuals with the following conditions:

• Severe Liver Failure: Patients whose liver function is significantly compromised may not be able to tolerate the treatment.
• Widespread Cancer: If the cancer has spread extensively to other parts of the body beyond the liver, this targeted therapy will not be effective.
• High Radiation Risk to Lungs: If the initial mapping test indicates that a significant amount of radiation would travel to the lungs, the procedure is contraindicated to prevent potential damage.
• Pregnancy: The treatment is not performed on pregnant women due to the risk of radiation exposure to the fetus.

What are the advantages?

Radioembolization offers several significant advantages for patients with liver cancer, establishing it as a valuable and advanced treatment option:

• Targeted Therapy and Tissue Preservation: Radiation is delivered in high concentrations directly to the tumor. This approach maximizes the impact on cancer cells while sparing the surrounding healthy liver tissue from significant damage.
• Minimally Invasive Nature: As a minimally invasive procedure, it is performed through a small incision using a catheter, which avoids the need for major surgery. This typically results in shorter hospital stays and a faster recovery.
• Fewer Systemic Side Effects: Unlike traditional chemotherapy, the radioembolization treatment is localized to the liver. This greatly reduces widespread side effects such as hair loss, nausea, or severe fatigue.
• A Bridge to Curative Surgery: By effectively shrinking tumors, radioembolization can make patients who were previously considered inoperable eligible for potentially curative surgery or a liver transplant.

Are there any side effects of using Radioembolization?

Like any medical procedure, radioembolization can have some side effects. The most common is known as “post-embolization syndrome,” which may include symptoms like fatigue, a mild fever, nausea, and abdominal pain. These symptoms are typically mild and temporary, usually resolving on their own within a week following the treatment. While serious side effects are rare, the doctor will thoroughly discuss all potential risks and benefits with the patient before the procedure to ensure they are fully informed and comfortable.

What should be considered after the application?

After the radioembolization procedure, it is crucial for patients to arrange for someone to drive them home, as they may still be feeling the effects of sedation. For the first few days following the treatment, specific radiation safety measures must be strictly followed. This primarily involves limiting close contact with children and pregnant women to minimize any potential radiation exposure. The medical team will provide detailed guidelines on all necessary precautions. To monitor the treatment’s effectiveness, regular follow-up imaging, such as MRI or CT scans, will be scheduled. These scans are vital for tracking the tumor’s response and ensuring optimal long-term care.